Two new metabolites, a diglyceride ester, corticaglyceride (1) and a sphingolipid, corticaceramide (5) were isolated and characterized from the Red Sea sponge Negombata corticata (Carter) . Other previously reported compounds including nervonic acid (2) , 24-methylene cholesterol (3) and cholesterol (4) were also isolated for the first time from this genus. GLC analysis of the unsaponifiable matter revealed that it contained a high percentage of hydrocarbons (89.474%) with n-hexacosane as a major component (10.979%) . Furthermore, the identified sterol represents 7.162%. GLC analysis of the fatty acid methyl esters revealed that nervonic acid is the major fatty acid (73.782%). Compound 3 showed anti-inflammatory activity, while compounds 1 and 5 showed mild anti-oxidant properties.
INTRODUCTION
Marine sponges continue to be a rich source of new secondary metabolites with a wide range of biological activities. 1 Marine natural products chemists have described a wonderful array of pharmacologically-active metabolites from marine sponges. 2 The genus Negombata is represented in the Red Sea by two species, namely Negombata magnifica (Keller) (formerly Latrunculia magnifica) and Negombata corticata (Carter), family Podospongiidae. 3 Genus Negombata was shown to be a source of biologically active macrolides. [4] [5] [6] [7] [8] Lipid classes, sterols and fatty acid are potentially excellent biomarker compounds in marine samples due to their stability and diversity of their structures. They are present in all eukaryotes and share with phospholipids a structural function in membranes due to their role in chemotaxonomic purposes and for food web tracing. 9 Sphingolipids have emerged as a new class of modulators of various cell functions. Ceramides, which are the central molecule in the biosynthesis of sphingolipids and glycosphingolipids, are involved in the regulation of different cellular events, including cell senescence, differentiation, and apoptosis. Many biologically active sphingolipids have been isolated from different marine organisms. 10 This study describes the investigation of lipoidal content of the sponge Negombata corticata, in addition to the isolation and identification of biologically active compounds. Chemical investigation of the Red Sea Sponge Negombata corticata led to the isolation and structure elucidation of two new metabolites diglyceride ester, corticaglyceride (1) and sphingolipid, corticaceramide (5) along with the previously known metabolites, nervonic acid (2), 24-methylenecholesterol (3) and cholesterol (4) for the first time from genus Negombata. Nervonic acid is the most important of the tetracosanic acids (C 24 ) which is a significant component of many sphingolipids. This acid was isolated from Jojoba oil and Honesty seed oil (Lunaria beeiennis). 11 Nervonic acid is a major component of the human brain. Its level increases in infant brain until the 5 th year of age, and may be used as an indicator of brain maturity. Levels of nervonic acid were found to be lower in patients with demyelinating diseases and schizophrenia. Nervonic acid is currently being promoted for regulation of brain cell function and increasing mental activity. 12 Biological evaluation of isolated metabolites revealed that, 1 and 5 possess anti-oxidant activity. Compound 3 was found to exhibit anti-inflammatory activity.
EXPERIMENTAL

Biological material, collection and identification
The Negombata corticata, (Carter) (coll. no. SAA-8) was collected by SCUBA at depths of 15-20 m from Safaga at the Egyptian Red Sea. The sponge materials were frozen immediately and kept frozen at -20° until processed. 
General experimental procedures
The 1 H-and 13 C-NMR spectra were measured on a JEOL 500 spectrometer and mass spectrometry was performed using a QSTAR ® hybrid pulsar-i instrument (Applied Biosystems, Foster City, CA) equipped with a nano spray ion source. Stuart Scientific apparatus for melting point determination, Stuart Scientific Co. LTD, Great Britain, USA. The UV spectra were measured by a double -beam Shimadzu UV-Visible spectrophotometer (model UV-1601 PC, Japan). IR spectra were measured by Nicolit FT IR spectrophotometer range 400-4000,USA.
Fatty acid methyl esters were identified using Hewlett Packard (HP) gas liquid chromatography, series 6890 equipped with Flame Ionization Detector (FID). A capillary column (HP-INNOWAX, Polyethylene Glycol, 30 m x 530 µm, film thickness 1.00 µm) was used in separation of fatty acids. The injector port temperature was set at 250°( splitless mode) and a pressure of 14.81 psi and the detector cell at 275°. The flow rate of the carrier gas (N 2 ) was 30 mL/min. The initial column temperature was 70° and increased to 200° by the rate of 4°/min., then isothermally for a total run time of 32.5 min.
Unsaponifiable matters were identified using capillary column (HP-1 methyl siloxane, 30m x 350 µm, film thickness 2.65 µm) was used for separation. The injection port temperature was set at 260° (splitless mode) and the detector cell at 300°. The flow rate of the carrier gas (N 2 ) was 6 mL/min. The initial column temperature was 70° for 2 min and increased to 280° at a rate 10°/min, then isothermally for a total run time of 23 min.
Chromatographic materials
Pre-coated silica gel G-25 UV 254 plates were used for thin layer chromatography (20 x 20 cm) (E. Merck). Silica gel 60/230-400 mesh was used for column chromatography (EM Science). Gel permeation chromatography was carried out using Sephadex LH-20.
Experimental animals
Male albino rats weighing between 125-150 g were used.
Extraction and Isolation
The voucher specimen of the sponge Negombata corticata was freeze dried (400 gm dry weight), grounded and extracted with a mixture of MeOH/CH 2 Cl 2 (1:1) (3x2 L) at room temperature. The extract was evaporated under vacuum to afford 100 g of red oil. This extract was subjected to vacuum liquid chromatography on a flash silica gel using hexane, ethyl acetate and methanol gradient.
The fraction eluted using 10% ethyl acetate in hexane was concentrated to afford 5 g of reddish residue. Purification of this fraction was carried out by flash column chromatography on silica gel using hexane/ethyl acetate (95:5). Fractions with the same TLC pattern were combined and rechromatographed by flash column chromatography on silica gel using hexane/ethyl acetate (95:5). Final purification was carried out on Sephadex LH-20 using MeOH/CHCl 3 (1:1) to afford 1 (250 mg) (R f = 0.72, 10% ethyl acetate / hexane).
The fraction eluted with 20% ethyl acetate in hexane was concentrated to afford 7g of reddish residue. Purification of this fraction was carried out by flash column chromatography on silica gel using hexane/ethyl acetate (9:1), resulting in two fractions. The less polar fraction was rechromatographed by flash column chromatography on silica gel using hexane/ethyl acetate (9:1). Final purification was carried out on Sephadex LH-20 using MeOH/CHCl 3 (1:1) to afford 2 (100 mg) (R f = 0.65, 20% ethyl acetate / hexane).
The more polar fraction was rechromatographed by flash column chromatography on silica gel using hexane/ethyl acetate (9:1). Final purification was carried out on Sephadex LH-20 using MeOH/CHCl 3 (1:1) to afford 3 (80 mg) (R f = 0.5, 20% ethyl acetate / hexane) and 4 (4 g) (R f = 0.5, 20% ethyl acetate / hexane).
The fractions eluted with 30-60% ethyl acetate in hexane were combined and concentrated to afford 10 g of reddish residue. Purification of this fraction was carried out by flash column chromatography on silica gel using hexane/ethyl acetate (85:15). Fractions with the same TLC pattern were combined and rechromatographed by flash column chromatography on silica gel using hexane/ethyl acetate (85:15). This fraction was subjected to flash column chromatography on silica gel using 2% methanol in chloroform.
Final purification was carried out on Sephadex LH-20 using MeOH/CHCl 3 (1:1) to afford 5 (45 mg) (R f = 0.66, 10% methanol in chloroform).
Investigation of lipoidal matter
The extracted lipoidal matter (2 gm hexane fraction) of the sponge was saponified. 13 The unsaponifiable fraction was separated and weighed (1.2 g). A two-percentage chloroformic solution of the unsaponifiable matters was analyzed by GLC technique. Identification of the hydrocarbons and sterols was carried out by comparing the relative retention time of the peaks with those of the pure available authentics. The quantitative estimation of each peak was done by peak area measurement using a computing integrator. Results are shown in Table 1 .
The aqueous alkaline solution (aqueous mother liquor and washings) left after the separation of the unsaponifiable matters was acidified with concentrated hydrochloric acid (litmus paper). The liberated acids (0.4 g) were extracted with (4x50 ml) ether and their methyl esters were prepared. 14 A twopercentage chloroformic solution of the prepared fatty acid methyl ester (FAME) was analyzed by GLC. Identification of the fatty acids was carried out by comparing the relative retention time of the peaks with those of the pure available authentic standards. The quantitative estimation of each peak was done by peak area measurement using a computing integrator. Results are shown in Table 2 .
Hydrolysis of 1 and 5
Compound 1 was refluxed with 10% ethanolic KOH and benzene for 24 h. After adding H 2 O, the reaction mixture was extracted with ether. The aqueous alkaline solution was acidified with concentrated HCl. The reaction mixture was extracted with ether. The resulting ether-soluble fraction was concentrated to yield a fatty acid. Compound 5 was cleaved by the same method.
Preparation of fatty acid methyl esters of 1, 2 and 5
Prepared Table 5 .
Biological evaluation 1-Anti-inflammatory test for compound 3
Hind paw-oedema method was used where 4% formalin solution was used to induce paw skin oedema. A group of animals (5 rats) were given dexamethasone subcutaneously at a dose of 20 mg/kg. A second group (5 rats) were injected test compound 3 subcutaneously between the sholder blades with a dose of 20 mg/kg. Five rats were taken as control group. 15 Percentage increase in paw thickness were calculated and presented as mean ± SE ( Table 6 ). The data were computed using SPSS program and analyzed by one-way analysis of variance (ANOVA) followed by PostHoc test (Bonfrroni) for multiple comparisons. Significant results were determined as p < 0.05.
2-Anti-oxidant test
TLC-based 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) autographic chemical assay was used. Isolated compounds were dissolved in DMF at a concentration of 2 mg/mL. A 4 µl volume of each compound was applied in the form of a spot (4-5 mm in diameter) on silica gel GF plates. The residual DMF was removed under vacuum (15-20 min). A similar amount of Vitamin E in DMF was used as positive antioxidant control. The radical-scavenging effects of the isolated compounds were detected on the TLC plate using a spray reagent composed of a 0.2% (w/v) solution of 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) in MeOH. The plate was observed 30 min after spraying. Active compounds were observed as yellow spots against a purple background.
Relative radicalscavenging activity was assigned as "strong" (compounds that produce an intense bright yellow zone), "medium" (compounds that produce a clear yellow spot), "weak" (compounds that produce a weakly visible yellow spot), or "not active" (compounds that produce no sign of any yellow spot). 16 Vitamin E was taken as positive antioxidant control which produced an intense bright yellow zone. 
RESULTS AND DISCUSSION
Compound 1:
The structure elucidation of 1 began with an analysis of its 13 C-NMR spectrum and DEPT which indicated the presence of two oxygenated methylenes at δ 62.2 and δ 62.2, one oxgynated methene at δ 68.9 together with two CO for two ester moieties at δ173.4 and 173.0. Also the presence of two disubstituted olefinic moieties were confirmed by 13 C-NMR resonances at δ 130.9, 129.9, 128.8 and 128.0. The above mentioned findings were consistent with the presence of a diglyceride ester. GC analysis of the fatty acid methyl ester of compound 1 was carried out after hydrolysis. Identification of the fatty acids was carried out by GLC analysis of fatty acid methyl esters by comparing the relative retention time of the peaks with those of the pure available authentic samples. GLC analysis revealed that 1 contains the unsaturated fatty acids, nervonic acid and oleic acid. The placement of the fatty acid at C-1 and C-3 of the diglyceride ester was assigned by 1 
revealed that 1 is 1,3 diglyceride ester (Fig. 1 ). Detailed analysis of COSY and HMBC correlations were found to be in complete agreement with the proposed structure for 1 ( Table 3 ). The name corticaglyceride was assigned to the new diglyceride (Tetracos-9-enoic acid 2-hydroxy-3octadec-9-enoyloxy-propyl ester). 
2:
The structure elucidation of 2 began with an analysis of its MS data that yielded an m/z peak of 366 which combined with detailed analysis of the 13 C spectrum and DEPT indicated a molecular formula of C 24 H 46 O 2 representing to two units of unsaturation. One of them was assigned as a carbonyl functional group for carboxylic acid where 13 C-NMR of 2 showed a signal at δ 180.2 (s). The other was suggested by appearance of signals at δ 130.9 and 128.8 assigned for olefinic carbons. This finding is consistent with the presence of a fatty acid. GLC analysis of the prepared methyl ester of compound 2 was carried out and by comparing the relative retention time of the peak with those of the pure available authentic standards. This compound is nervonic acid. Detailed analysis of COSY correlations were found to be in complete agreement with the proposed structure for nervonic acid (Table 4) .
Compounds 3 and 4:
These were identified as 24-methylene cholesterol and cholesterol by comparison of their spectroscopic properties with those reported in the literature. 17&18
Compound
5:
The structure elucidation of 5 began with an analysis of its MS data. The high resolution ESI-TOF mass spectrum of 5 displayed a pseudo-molecular ion peak at m/z 536.4807 [M + H] + which combined with detailed analysis of the 13 ( 3 J CH ), H 2 6/C-8 ( 3 J CH ), H 2 -7/C-8 ( 2 J CH ), H 2 -7/C-9 ( 3 J CH ), H-8/C-9 ( 2 J CH ) leading to assignment of the C-4/C-5/C-6/C-7/C-8/C-9 (Fig. 2) . The position and geometry of the double bonds were confirmed by 1 H-1 H COSY analysis and coupling constant data. The J 4,5 (15.00 Hz) and J 8,9 (15.30 Hz) values indicating the trans geometry of the double bonds. Therefore, 5 was assigned as a new 4E, 8E-sphingadiene type ceramide, reported here for the first time. GC-MS analysis of the fatty acid methyl ester of compound 5 was carried out after hydrolysis and yielded an eicosanoic acid methyl ester. These results suggested that 5 was an N-acyl eicosanoic acid derivative of C 14 amino alcohols. The chemical shifts of C-1 (δ 62.5), C-2 (δ 54.0), C-3 (δ 76.8), and C-1' (δ 174.0) were very similar to those of the neurotrophic ceramide (4E,6E,2S,3R)-2-N-eicosanoyl-4,6-tetradecasphingadienine, which was recently reported. 19 This evidence indicated the absolute configurations at C-2 and C-3 to be 2S and 3R, respectively. Accordingly, the structure of 5 was assigned to be (4E,8E,2S,3R)-2-N-eicosanoyl-4,8tetradecasphingadienine.
Detailed analysis of COSY and HMBC correlations were found to be in complete agreement with the proposed structure for 5 ( Table 5 ). The name corticaceramide was assigned to the new sphingolipid.
Biological evaluation of isolated metabolites revealed that compound 5 possesses "medium" anti-oxidant activity while compound 1 has "weak" anti-oxidant activity. Compound 3 was found to exhibit anti-inflammatory activity comparable to dexamethasone ( Table 6 ).
The isolated lipids, sterols and fatty acids in this study are also expected to serve as biomarkers indicating the presence of biological activity as well as for chemotaxonomic purposes. 
